Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 10
Submit an article Journal homepage
550
Views
8
CrossRef citations to date
0
Altmetric
Reviews

The potential combination of BCL-2 inhibitors and ibrutinib as frontline therapy in chronic lymphocytic leukemia

Andrew AwDepartment of Medicine, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ottawa, Canada;
&
Jennifer R. BrownCLL Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; ;Department of Medicine, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
Pages 2287-2297 | Received 18 Feb 2017, Accepted 19 Mar 2017, Published online: 09 May 2017

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Francesco Paolo Tambaro, Danilo De Novellis & William G Wierda. (2021) The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View. Journal of Experimental Pharmacology 13, pages 923-935.
Read now
Laura S. Samples & Solomon A. Graf. (2018) On the front line: first choice pharmacotherapeutics for chronic lymphocytic leukemia. Expert Opinion on Pharmacotherapy 19:15, pages 1675-1684.
Read now
Steven Grant. (2018) Rational combination strategies to enhance venetoclax activity and overcome resistance in hematologic malignancies. Leukemia & Lymphoma 59:6, pages 1292-1299.
Read now

Articles from other publishers (5)

Luca Laurenti, Lydia Scarfò, Anna Maria Frustaci, Alessandro Sanna, Emilia Iannella, Morena Caira, Paola Finsinger, Silvia Schifano, Benedetta Neri, Stefano Molica & Francesca Romana Mauro. (2023) Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience. Hematological Oncology.
Crossref
Zhuojun Liu, Jia Liu, Tianming Zhang, Mingxia Shi, Xiaofang Chen, Yun Chen & Jian Yu. (2020) Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo. Pharmacological Research 151, pages 104512.
Crossref
Herbert Eradat. (2019) Venetoclax for the Treatment of Chronic Lymphocytic Leukemia. Current Hematologic Malignancy Reports 14:5, pages 469-476.
Crossref
Clare M. Adams, Sean Clark-Garvey, Pierluigi Porcu & Christine M. Eischen. (2019) Targeting the Bcl-2 Family in B Cell Lymphoma. Frontiers in Oncology 8.
Crossref
Kirsten Fischer & Michael Hallek. (2017) Optimizing frontline therapy of CLL based on clinical and biological factors. Hematology 2017:1, pages 338-345.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.